Funnelfeedr Logo

Disruptive Pharma AB (publ)

Sverige556755-3226Active

Swedish biotech developing novel kidney disease therapies based on proprietary peptides.

Biotechnology Companyguardtherapeutics.com

Översikt

5–9
Anställda
≤1t SEK
Omsättning
2008
Grundat

Nyckelbeslutsfattare

Tobias L Agervald

CEO

@guardtherapeutics.com+46867XXXXX

Karin Botha

CFO

Khatereh Ahmadi

Board Member

Torbjörn Larsson

Head of Chemistry, Manufacturing and Control

+9 fler kontakter i Funnelfeedr

Beskrivning

Guard Therapeutics is a Swedish clinical-stage biotechnology company dedicated to developing novel therapies for kidney diseases, addressing significant unmet medical needs. The company's drug candidates are uniquely based on the body's own protein, alpha-1-microglobulin. Their lead candidate, RMC-0...

Taggar

B2BHealthcarePharmaceuticalsProfessional ServicesPublicly ListedTechnologyWhite Collar

Nyckelord

BiotechnologyClinical StageDrug DevelopmentKidney DiseasePharmaRMC-035

Teknikstack

YiijQueryVimeoBootstrapCraft CMSFont AwesomeModernizrPHP

Företagsinformation

Bransch
Annan naturvetenskaplig och teknisk forskning och utveckling
Juridisk form
Aktiebolag
Momsnummer
SE556755322601

Beslutsfattare

13 kontakter i Funnelfeedr

Tobias L Agervald

CEO

@guardtherapeutics.com+46867XXXXX

Karin Botha

CFO

Khatereh Ahmadi

Board Member

Torbjörn Larsson

Head of Chemistry, Manufacturing and Control

Sara Thuresson

Head of Clinical Operations

Fredrik Lehmann

Board Member

Göran Forsberg

Board Member

Johannes Hulthe

Board Member

Michael Reusch

CMO

Johan Bygge

Chairman of the Board

Hege Hellström

Board Member

Peter Gilmour

Head of Preclinical Science

Övriga kontakter

Mikael Widell

IR Contact

@guardtherapeutics.com

Liknande företag

20 liknande företag i Funnelfeedr

Utforska mer

Frågor om Disruptive Pharma AB (publ)

Vill du se Funnelfeedr i praktiken?

Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.

Boka en demo